- Home
- OM
as 05-30-2025 4:00pm EST
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
| Founded: | 2003 | Country: | United States |
| Employees: | N/A | City: | SAN JOSE |
| Market Cap: | 305.5M | IPO Year: | 2020 |
| Target Price: | $33.00 | AVG Volume (30 days): | 267.6K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -26.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.85 - $72.60 | Next Earning Date: | 05-07-2025 |
| Revenue: | $115,273,000 | Revenue Growth: | -7.84% |
| Revenue Growth (this year): | 10.8% | Revenue Growth (next year): | 11.99% |
Latest Outset Medical Inc. News
OM Breaking Stock News: Dive into OM Ticker-Specific Updates for Smart Investing
MT Newswires
11 days ago
RBC Raises Price Target on Outset Medical to $21 From $14, Keeps Sector Perform Rating
GlobeNewswire
18 days ago
Outset Medical Appoints Industry Veteran Kevin O’Boyle to its Board of Directors
Simply Wall St.
22 days ago
Outset Medical First Quarter 2025 Earnings: Beats Expectations
GlobeNewswire
23 days ago
Outset Medical to Present at RBC Global Healthcare Conference
Thomson Reuters StreetEvents
24 days ago
Q1 2025 Outset Medical Inc Earnings Call
MT Newswires
24 days ago
RBC Raises Price Target on Outset Medical to $14 From $12, Keeps Sector Perform Rating
GuruFocus.com
24 days ago
Outset Medical Inc (OM) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Zacks
24 days ago
Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates
Compare OM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OM Outset Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.